No Data
No Data
Dimerix Partners With UK's Rare Kidney Disease Registry for Recruitment for ACTION3 Phase Three Clinical Trial
Euroz Hartleys Adjusts Dimerix's Price Target to AU$0.91 From AU$0.86; Keeps at Speculative Buy
Why Dimerix, Paladin Energy, Pilbara Minerals, and Resolute Mining Shares Are Storming Higher Today
Dimerix Begins Recruiting Young Kidney Disease Patients in Mexico for Phase 3
Australian Shares Climb Ahead of US Inflation Data; Galan Lithium Falls 7% Amid Capital Raise Plans
Why Dimerix, Life360, S2 Resources, and SG Fleet Shares Are Sinking Today
No Data
No Data